Pharmaceuticals and Biotech | Media Room

Press Release Aug 15, 2023

Longwood Healthcare Leaders to Convene Top Biotech and Pharmaceutical Leaders and Researchers

Press Release Aug 14, 2023

GeneTex Addresses GPCR Targets With Its Recombinant Monoclonal Antibody Production Platform

Press Release Aug 14, 2023

Lactiga Receives FDA 'Rare Pediatric Disease' Designation for Groundbreaking Mucosal Immunoglobulin Therapy for Common Variable Immunodeficiency Disease

LCTG-001 on course to be the first FDA-approved biologic from human milk Read More

Press Release Aug 11, 2023

BillionToOne Publishes UNITY Fetal RhD and Fetal Antigen NIPT Clinical Validity Demonstrating >99.9% Accuracy

In a clinical validation study published on Scientific Reports, UNITY RhD NIPT and Fetal antigen NIPT demonstrated 100% sensitivity, 100% specificity, 99.9% precision with 0.1% no-call rate across 3,921 NIPT assays. Read More

Press Release Aug 10, 2023

Elixia Health Enters Phase I Clinical Trials Market

Tampa-based site expands study capabilities and patient comfort Read More

Press Release Aug 8, 2023

LighthouseAI Secures $2.25M Investment Led by Healthy Ventures, Innovating Pharmaceutical Supply Chain Compliance

Funding Accelerates the Development of Compliance Automation Solutions Read More

Press Release Aug 8, 2023

CanariaBio Announces Enrollment Completion of Phase 2 Study of Oregovomab in Combination With Niraparib in the Treatment of Recurrent Ovarian Cancer

Press Release Aug 3, 2023

CustomerInsights.AI Recognized in Gartner's 2023 Hype Cycle for Data & Life Sciences Commercial Operations

Press Release Aug 1, 2023

iTolerance, Inc. and Northway Biotech Announce Partnership Agreement for Manufacturing of Streptavidin-FasL Fusion Protein for Innovative iTOL-100 Immunomodulatory Technology

iTOL-100 technology has broad applicability and can be applied to both allogenic and stem cell-derived organoids across a number of diseases. Manufacturing agreement supports advancement of iTolerance's development of iTOL-100 towards first in human clinical study for lead program, iTOL-102. Read More

Press Release Jul 27, 2023

Peptomyc Announces the Approval of Its Phase 1b Trial Testing OMO-103 in Combination With Standard of Care in PDAC Patients

OMO-103 in Phase 1b clinical trial Read More

Press Release Jul 25, 2023

BioPharma Connections Adds LGM Pharma as a Strategic Client Partner

LGM Pharma opts to engage with BioPharma Connections for business development services Read More

Press Release Jul 24, 2023

HanchorBio Announces Taiwan FDA IND Approval for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies

HanchorBio Received IND Approval of HCB101 Multi-Regional Clinical Trial By Taiwan FDA Read More

Press Release Jul 20, 2023

LabWare Selected as Honoree of 2023 Drexel LeBow Analytics 50 Award

LabWare honored for analyzing business challenges, creating a solution and impacting the industry Read More

Press Release Jul 18, 2023

Oxford Biomedica Implements Sapio Sciences' Electronic Laboratory Notebook

Sapio's No-Code ELN to Provide Enhanced Collaboration, Unified Data Access, and Flexible Workflows to viral vector CDMO Oxford Biomedica Read More

Press Release Jul 18, 2023

Oxford Biomedica Implements Sapio Sciences' Electronic Laboratory Notebook

Sapio's No-Code ELN to Provide Enhanced Collaboration, Unified Data Access, and Flexible Workflows to viral vector CDMO Oxford Biomedica Read More

Press Release Jul 14, 2023

POP Biotechnologies and EuBiologics' EuCorVac-19 COVID-19 Vaccine Hits Target in Phase 3 Trial

Press Release Jul 12, 2023

AmplifyBio Completes Acquisition of Intellectual Property to Offer Non-Viral Gene Editing Services for Clients

Press Release Jul 11, 2023

Gb Sciences' First-in-Class Parkinson's Disease Therapy Successfully Completes Dose Response Study at the University of Lethbridge

The Parkinson's disease market is expected to grow to $12.8 billion by 2028. Read More

Press Release Jul 6, 2023

NatureMetrics Adopts Sapio Science's No-Code LIMS/ELN Platform to Accelerate Environmental DNA Monitoring

Sapio LIMS/ELN Provides NatureMetrics With a Configurable Workflow and Data Solution That Adapts as eDNA Technology Rapidly Evolves Read More

Press Release Jun 29, 2023

The Methodical Group Named 50 Fastest Growing Companies of 2023

Accelerating Industry Standards: The Methodical Group Secures Spot as One of the 50 Fastest Growing Companies of 2023, Pioneering Breakthrough Solutions Across Multiple Sectors Read More

Press Release Jun 29, 2023

BioMed X Institute Starts Its First Research Project With Sanofi on Artificial Intelligence for Drug Development

Powered by Sanofi, a new BioMed X research team will develop a computational platform designed to accelerate drug development. Read More

Press Release Jun 28, 2023

Antares Vision Group Becomes the First DSCSA Compliance Software Awarded a Spot on the GSA MAS Contract With Lovell Government Services

Press Release Jun 22, 2023

Contract Pharmacal Corp. Wins CVS's 2022 Leading With Heart Award

Press Release Jun 22, 2023

PharmaNest Launches Its Digital Pathology Spatially Resolved, Quantitative Tissue Panels to Quantify Tissue Injury and Inflammation in the Context of Fibrotic Conditions

PharmaNest, a leader in high resolution quantitative Digital Pathology and Artificial Intelligence, announces today the launch new quantitative tissue panels to properly quantify tissue injury and inflammation in the context of multiple fibrotic conditions, from discovery models to clinical development. Such spatially resolved datasets can be fused with other spatially resolved biology methods. Read More

Press Release Jun 22, 2023

International Medical Lasers Industry Leadership Drives 350% Growth Rate, New Offering of DEKA Laser Accessories for Surgical Scar Revision

IML's Expertise in Global Medical Device Marketplace Drives Five-Year Record Growth Read More

Press Release Jun 20, 2023

Nemysis Limited Signs Heads of Terms for IHAT Sales and Marketing

Nemysis has entered into Heads of Terms for two nonexclusive sales and marketing agreements with two potential partners for the sale and marketing of its IHAT product within the Italian market. Read More

Press Release Jun 19, 2023

PharmaNest to Present Six Digital Pathology Abstracts at the International Liver Congress-EASL 2023, Including Liver Related Clinical Outcomes Prediction Results in NASH

PharmaNest, a leader in high resolution, single-fiber, quantitative Digital Pathology and Artificial Intelligence, showcases the utility and performance of its FibroNest Ph-FCS continuous fibrosis biomarker for the quantification of the severity of fibrosis and prognostics of liver related clinical events in NASH. Read More

Press Release Jun 16, 2023

Late-Breaking Results of a Preclinical Efficacy Study Presented at ENDO 2023 Show Seraxis SRE Sustainably Reverses Type-1-Diabetes Hyperglycemia

Press Release Jun 15, 2023

OKRA.ai, an Envision Pharma Group Company, Appoints Dr. Yahya Anvar to Senior Leadership Position

Press Release Jun 15, 2023

With an Eye on the Future, Biolog Launches Odin

Press Release Jun 13, 2023

Envision Pharma Group's Omnichannel Strategy and Creative Agency Team Recognized as a One to Watch by Medical Marketing + Media for 2023

Recognition showcases the agency's distinction amidst its competition and the value it has added for clients Read More

Press Release Jun 13, 2023

Pro-ficiency Acquires Compass Group Partners and Affiliated Assets

Press Release Jun 13, 2023

NSI Lab Solutions Launches MicroVive: The Only 30-Day Rehydration Fluid for Microbiological Cultures

Press Release Jun 13, 2023

New Webinar Presents the Implications of Alabama's Designated Representative Rule for DSCSA Compliance

A Special Event Taking Place Live on June 20, 2023 Read More

Press Release Jun 13, 2023

PharmaLink Announces Execution of Returns Processing Service Agreement With Merck

Press Release Jun 12, 2023

PharmaLink Announces Acquisition of PharmaReturns

Press Release Jun 6, 2023

GeneTex Launches PD-L1 Antibody Comprehensively Validated by MS Validated Antibodies GmbH for Immunohistochemistry

Press Release Jun 1, 2023

Pro-ficiency Launches Pf Library to Expand Study Training Service Suite

Press Release May 25, 2023

ZAGENO Secures $33M Funding to Revolutionize Life Science Research Procurement

ZAGENO Empowers Life Science Research with Unparalleled Efficiency and Cost Savings Read More

Press Release May 25, 2023

AmplifyBio Celebrates 2 Years of Innovative Solutions, Preclinical Drug Development and Safety

Press Release May 24, 2023

Reveal Lasers LLC Launches Eterna, a Revolutionary Radiofrequency Device

New Radiofrequency Treatment Reduces Fine Facial Lines and Wrinkles and Tightens Skin Through Soft Tissue Coagulation Without the Need for Consumables Read More

Press Release May 24, 2023

Northway Biotech Set to Launch Advanced Microbial and Mammalian GMP Facilities in Massachusetts

Press Release May 23, 2023

PharmaCord Announces Promotion of Denise Von Dohren to Senior Vice President, Patient Services

Press Release May 23, 2023

Former Pyxant Labs and ImaBiotech Announce New Unified Brand as Aliri

Press Release May 20, 2023

Neurimmune: Promising Phase 1 Results for Antibody NI006 in ATTR Cardiomyopathy Published in the New England Journal of Medicine

Results also presented during late-breaking session at ESC Heart Failure congress 2023 Read More

Press Release May 18, 2023

CliniOps Awarded Patent for Pioneering System to Collect Location Agnostic Clinical and Non-Clinical Data

Ensure Diversity in clinical trials removing 'zip code as a barrier' Read More

Press Release May 16, 2023

ZeptoMetrix Launches PROtrol: Quality Control Material for the Lateral Flow Immunoassay Market

Press Release May 16, 2023

tiakis Biotech AG and Northway Biotech: Successful Tech Transfer and Expansion of Manufacturing Capabilities for Tiprelestat

Press Release May 16, 2023

Owkin Receives European Medicines Agency Letter of Support for Innovative AI-Driven Approach to Oncology Trial Analysis

EMA offers endorsement for AI optimization of clinical trials. Two Owkin AI models significantly improve the discrimination accuracy for overall survival in hepatocellular carcinoma and mesothelioma. Owkin to develop on-demand prognostic scores for other indications to further reduce clinical trial failure rates Read More

Press Release May 16, 2023

Ambit Hires Jonathan Woodring as Chief Innovation Officer

Former IPM.ai executive to drive data and analytics product strategy, development, and commercialization. Read More

Press Release May 15, 2023

Waypoint Orthopedics Announces FDA Clearance of the Waypoint GPS

Press Release May 15, 2023

AmplifyBio Adds Manufacturing Capabilities to Expand Service Portfolio

AmplifyBio is adding manufacturing services, starting with cell therapy and plasmids, to its growing capabilities to support the safe development of advanced therapies. Read More

Press Release May 10, 2023

FarmaKeio Outsourcing Announces Patented Formulation of Revolutionary Hormone Therapy Pellet

FarmaKeio Outsourcing is proud to announce the release of its latest innovation, the only patented hormone pellet with triamcinolone developed in an FDA-registered 503B outsourcing facility. The pellet is set to provide a new and revolutionary solution to hormone replacement therapy for men and women. Read More

Press Release May 9, 2023

Just in Time GCP Ranks Among Highest-Scoring Businesses on Inc. Magazine's Annual List of Best Workplaces for 2023

Just in Time GCP named among Best Workplaces by Inc. Magazine Read More

Press Release May 9, 2023

Scailyte Announces Jan Lichtenberg, CEO at inSphero, as a Member of the Board of Directors

Press Release May 9, 2023

Florence Healthcare Announces the Launch of the Site Enablement League to Accelerate Clinical Trial Innovation and Enhance Site Experience

Revolutionizing Clinical Trials: Site Enablement League Unites Industry Leaders to Accelerate Cures and Optimize Site Experience Read More

Press Release May 9, 2023

FamilieSCN2A Foundation Announces Inaugural $2.5M Hodgkin-Huxley Research Award

Yang Yang, PhD, of Purdue University is the recipient of a major 5-year grant for Personalized Treatment Development in SCN2A-Related Disorders Read More

Press Release May 9, 2023

Envision Pharma Group Announces Appointment of Dr. Deepti Sodhi Jaggi to Board of Directors

Press Release May 8, 2023

Reveal Lasers Announces Acquisition of Med Rep Meeting

Press Release May 4, 2023

Cuverd Brings Prescription Costs Savings Solutions to HUB Employer Clients

Cuverd takes the mystery out of getting the lowest out-of-pocket prescription costs for employees and their families struggling to start and stay on needed therapies. Read More